Welcome to Medications.com

Avapro News

UPDATE: Bristol-Myers Reports Narrowed Loss Amid Charges - CNNMoney.com

Another big-seller, the hypertension medication Avapro, saw sales climbed 7% to $328 million . That product, whose key patent expires in 2012, ...

http://money.cnn.com/news/newsfee... | Posted: Thu Jan 31 10:32:51 -0500 2008

Ahead of the Bell: Bristol-Myers Squibb - CNNMoney.com

"Valuation now better reflects the company's growth challenges beyond Plavix, Avapro, and Abilify," Kelly wrote in a client note. ...

http://money.cnn.com/news/newsfee... | Posted: Thu Jan 24 09:23:42 -0500 2008

Grocer's $4 prescriptions follow trend as competition intensifies - Houston Chronicle

"Last week I had a patient call and ask to be changed from Avapro to Benicar because it was a few dollars cheaper," he said. ...

http://www.chron.com/disp/story.m... | Posted: Thu Feb 07 01:36:06 -0500 2008

Ahead of the Bell: Bristol-Myers Squibb - CNNMoney.com

'Valuation now better reflects the company's growth challenges beyond Plavix, Avapro, and Abilify,' Kelly wrote in a client note. ...

http://money.cnn.com/news/newsfee... | Posted: Thu Jan 24 09:42:32 -0500 2008

Sector Snap: Pharma Shares Trade Mixed - Houston Chronicle

"The patent cliff in 2012, which includes Plavix, (hypertension treatment) Avapro and returning (bipolar drug) Abilify to Otsuka create a significant hurdle ...

http://www.chron.com/disp/story.m... | Posted: Thu Dec 06 12:17:58 -0500 2007

BMS Not Interested In Merger With Sanofi-Aventis - Source - CNNMoney.com

... has substantial research capability and the two groups have been historic partners in the marketing of Plavix and blood pressure treatment Avapro. ...

http://money.cnn.com/news/newsfee... | Posted: Wed Nov 28 09:26:42 -0500 2007

Bristol-Myers Seen Cutting Jobs, Plants; Mulling Unit Sales - CNNMoney.com

Patel also suggested Bristol might even want to get out of its co-marketing arrangement with Sanofi-Aventis for the anti-hypertension drug Avapro. ...

http://money.cnn.com/news/newsfee... | Posted: Fri Nov 30 12:53:03 -0500 2007

update 2-bristol profit jumps as plavix continues rebound - Reuters.uk

... of blood pressure treatment avapro rose 12 percent to $309 million, while sales of colon cancer drug erbitux grew 6 percent to $185 million. continued. ...

http://investing.reuters.co.uk/in... | Posted: Thu Oct 25 08:53:07 -0400 2007

FDA approves Sanofi-Aventis's Avalide for additional use - Pharmaceutical Business Review

Now with Avapro (irbesartan) and Avalide physicians have more therapeutic options to treat mild, moderate and severe hypertension."

http://www.pharmaceutical-busines... | Posted: Tue Nov 20 22:07:10 -0500 2007

Brushup on Bristol-Myers Reveals Upside - Barron's

Our sales forecasts for (hypertension drug) Avapro were increased by $20 million-$200 million during 2007-2010. There were no changes to our Avapro sales ...

http://online.barrons.com/article... | Posted: Mon Nov 19 12:59:47 -0500 2007




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea